Rui Huang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 34

Top Topics

Structure Activity Relationship

Hepatitis B Virus

Top Venues

Alimentary pharmacology & therapeutics

Hepatology communications

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Jian Wang, Shaoqiu Zhang, Zhiyi Zhang, Chao Wu, Rui Huang
Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D. Alimentary pharmacology & therapeutics 59 (9) (2024)
Rui Huang, Jiacheng Liu, Jian Wang, Yuanwang Qiu, Li Zhu, Yiguang Li, Yilin Liu, Jie Zhan, Ruifei Xue, Suling Jiang, Yu Geng, Yawen Wan, Ming Li, Minxin Mao, Dongmei Gao, Yan Gu, Yao Zhang, Shengxia Yin, Xin Tong, Juan Xia, Xiaomin Yan, Weimao Ding, Yuxin Chen, Jie Li, Chuanwu Zhu, Chao Wu
Histological features of chronic hepatitis B patients with normal alanine aminotransferase according to different criteria. Hepatology communications 8 (1) (2024)
Jian Wang, Yifan Pan, Ye Xiong, Chao Wu, Rui Huang
Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients. Alimentary pharmacology & therapeutics (2024)
Rui Huang, Jiacheng Liu, Jian Wang, Yuanwang Qiu, Li Zhu, Yiguang Li, Yilin Liu, Jie Zhan, Ruifei Xue, Suling Jiang, Yu Geng, Yawen Wan, Ming Li, Minxin Mao, Dongmei Gao, Yan Gu, Yao Zhang, Shengxia Yin, Xin Tong, Juan Xia, Xiaomin Yan, Weimao Ding, Yuxin Chen, Jie Li, Chuanwu Zhu, Chao Wu
Histological features of chronic hepatitis B patients with normal alanine aminotransferase according to different criteria. Hepatology communications 8 (1) (2024)
Rui Huang, Jiacheng Liu, Jian Wang, Yuanwang Qiu, Li Zhu, Yiguang Li, Yilin Liu, Jie Zhan, Ruifei Xue, Suling Jiang, Yu Geng, Yawen Wan, Ming Li, Minxin Mao, Dongmei Gao, Yan Gu, Yao Zhang, Shengxia Yin, Xin Tong, Juan Xia, Xiaomin Yan, Weimao Ding, Yuxin Chen, Jie Li, Chuanwu Zhu, Chao Wu
Histological features of chronic hepatitis B patients with normal alanine aminotransferase according to different criteria. Hepatology communications 8 (1) (2024)
Rui Huang, Jiacheng Liu, Jian Wang, Yuanwang Qiu, Li Zhu, Yiguang Li, Yilin Liu, Jie Zhan, Ruifei Xue, Suling Jiang, Yu Geng, Yawen Wan, Ming Li, Minxin Mao, Dongmei Gao, Yan Gu, Yao Zhang, Shengxia Yin, Xin Tong, Juan Xia, Xiaomin Yan, Weimao Ding, Yuxin Chen, Jie Li, Chuanwu Zhu, Chao Wu
Histological features of chronic hepatitis B patients with normal alanine aminotransferase according to different criteria. Hepatology communications 8 (1) (2024)
Jian Wang, Tao Fan, Shaoqiu Zhang, Chao Wu, Rui Huang
Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 59 (8) (2024)
Jian Wang, Yifan Pan, Ye Xiong, Chao Wu, Rui Huang
Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients. Alimentary pharmacology & therapeutics 59 (11) (2024)
Jian Wang, Yifan Pan, Ye Xiong, Chao Wu, Rui Huang
Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients. Alimentary pharmacology & therapeutics 59 (11) (2024)
Jian Wang, Tao Fan, Shaoqiu Zhang, Chao Wu, Rui Huang
Letter: Association of serum growth differentiation factor 15 and liver-related outcomes in patients with MASLD. Alimentary pharmacology & therapeutics 60 (6) (2024)
Jian Wang, Tao Fan, Shaoqiu Zhang, Chao Wu, Rui Huang
Letter: Association of serum growth differentiation factor 15 and liver-related outcomes in patients with MASLD. Alimentary pharmacology & therapeutics (2024)
Jian Wang, Tao Fan, Shaoqiu Zhang, Chao Wu, Rui Huang
Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 59 (8) (2024)
Jian Wang, Yifan Pan, Ye Xiong, Chao Wu, Rui Huang
Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD. Alimentary pharmacology & therapeutics (2024)
Jian Wang, Shaoqiu Zhang, Zhiyi Zhang, Chao Wu, Rui Huang
Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D. Alimentary pharmacology & therapeutics 59 (9) (2024)
Rui Huang, Zhiyi Zhang, Jian Wang, Shaoqiu Zhang, Chao Wu
Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 58 (9) (2023)
Rui Huang, Jian Wang, Xiaomin Yan, Chuanwu Zhu, Chao Wu
Letter: improved alanine aminotransferase level in non-cirrhotic and low-viral load chronic hepatitis B patients treated with nucleotide/nucleoside analogues -authors' reply. Alimentary pharmacology & therapeutics 57 (5) (2023)
Rui Huang, Jian Wang, Xiaomin Yan, Chuanwu Zhu, Chao Wu
Editorial: considerations for expanding treatment in grey zone chronic hepatitis B patients-authors' reply. Alimentary pharmacology & therapeutics 57 (5) (2023)
Jian Wang, Xiaomin Yan, Li Zhu, Jiacheng Liu, Yuanwang Qiu, Yiguang Li, Yilin Liu, Ruifei Xue, Jie Zhan, Suling Jiang, Yu Geng, Yawen Wan, Ming Li, Minxin Mao, Dongmei Gao, Shengxia Yin, Xin Tong, Juan Xia, Weimao Ding, Yuxin Chen, Jie Li, Chuanwu Zhu, Rui Huang, Chao Wu
Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone. Alimentary pharmacology & therapeutics (2022)
Rui Huang, Jiacheng Liu, Jian Wang, Jie Li, Chao Wu
Letter to the Editor: Is HBV genotype strongly associated with HCC risk in patients with chronic hepatitis B? Hepatology (Baltimore, Md.) (2021)
Xiang-An Zhao, Jian Wang, Jie Wei, Jiacheng Liu, Guangmei Chen, Li Wang, Guiyang Wang, Juan Xia, Weihua Wu, Shengxia Yin, Xin Tong, Xiaomin Yan, Weimao Ding, Xiaoxing Xiang, Rui Huang, Chao Wu
Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase. Journal of clinical and translational hepatology 10 (2) (2021)
Rui Huang, Jiacheng Liu, Jian Wang, Chao Wu
Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis. Alimentary pharmacology & therapeutics 53 (9) (2021)
Rui Huang, Jiacheng Liu, Jian Wang, Xiaomin Yan, Chao Wu
Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 53 (6) (2021)
Rui Huang, Jiacheng Liu, Jian Wang, Chao Wu
Letter: rates and determinants of significant liver inflammation in chronic hepatitis B virus-infected patients with low ALT levels in the absence of significant fibrosis. Alimentary pharmacology & therapeutics 53 (1) (2021)
Jiacheng Liu, Jian Wang, Xiaomin Yan, Ruifei Xue, Jie Zhan, Suling Jiang, Yu Geng, Yilin Liu, Minxin Mao, Juan Xia, Shengxia Yin, Xin Tong, Yuxin Chen, Weimao Ding, Rui Huang, Chao Wu
Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis. Hepatology communications (2021)
Rui Huang, Jian Wang, Weihua Wu, Xiaomin Yan, Chao Wu
Letter to the Editor: Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. Hepatology (Baltimore, Md.) 71 (6) (2021)
Rui Huang, Juan Xia, Jian Wang, Yuxin Chen, Chao Wu
Letter: programmed death-1-a predictor for antiviral treatment in chronic hepatitis B. Authors' reply. Alimentary pharmacology & therapeutics 52 (4) (2020)
Rui Huang, Jian Wang, Zhaoping Zhang, Xiaomin Yan, Chao Wu
Letter to the Editor: Impact of Nonalcoholic Steatohepatitis on Liver-Related Outcomes in Chronic Hepatitis B. Hepatology (Baltimore, Md.) 71 (2) (2020)
Rui Huang, Jian Wang, Xiaomin Yan, Zhaoping Zhang, Chao Wu
Letter to the Editor: Noninvasive Markers of Advanced Liver Fibrosis in HBV/HIV Coinfected Patients. Hepatology (Baltimore, Md.) 70 (6) (2020)
Rui Huang, Jian Wang, Xiaomin Yan, Juan Xia, Chao Wu
Letter: risk of developing hepatocellular carcinoma in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation. Alimentary pharmacology & therapeutics 50 (5) (2020)
Yuxin Chen, Xin Tong, Yang Li, Bin Gu, Jiawei Yan, Yong Liu, Han Shen, Rui Huang, Chao Wu
A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients. PLoS pathogens 16 (9) (2020)
Juan Xia, Rui Huang, Yuxin Chen, Yong Liu, Jian Wang, Xiaomin Yan, Zhaoping Zhang, Chao Wu
Profiles of serum soluble programmed death-1 and programmed death-ligand 1 levels in chronic hepatitis B virus-infected patients with different disease phases and after anti-viral treatment. Alimentary pharmacology & therapeutics 51 (11) (2020)
Rui Huang, Weihua Wu, Jian Wang, Zhaoping Zhang, Chao Wu
Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes in non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 50 (3) (2020)
Rui Huang, Li Zhu, Jian Wang, Leyang Xue, Longgen Liu, Xuebing Yan, Songping Huang, Yang Li, Xiaomin Yan, Biao Zhang, Tianmin Xu, Chunyang Li, Fang Ji, Fang Ming, Yun Zhao, Juan Cheng, Yinling Wang, Haiyan Zhao, Shuqin Hong, Kang Chen, Xiang-An Zhao, Lei Zou, Dawen Sang, Huaping Shao, Xinying Guan, Xiaobing Chen, Yuxin Chen, Jie Wei, Chuanwu Zhu, Chao Wu
Clinical features of COVID-19 patients with non-alcoholic fatty liver disease. Hepatology communications (2020)
Rui Huang, Jian Wang, Weihua Wu, Xiaomin Yan, Chao Wu
Letter: clinical outcomes after long-term entecavir or tenofovir treatment in patients with hepatitis D and advanced fibrosis. Alimentary pharmacology & therapeutics 50 (4) (2020)